drugset / Trial / NCT02511587

Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun®

NCT02511587 ↗

Phase 4 Completed 116 enrolled Medical University of Vienna
RandomizedParallel-groupOpen-labelPrevention

Summary

FSME-Immun® is registered for application into the muscle. This study investigates if application under the skin leads to a comparable immune response.

Timeline

Start
2012-10
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject FSME-immune Vaccine — Intramuscular

Indications

No indication recorded.